Kidney transplant recipient thriving without antirejection drugs due to innovative treatment
Kyle Clark teared up as he made calls to his family from an intensive care unit at a hospital in China, where he’d been placed on dialysis.
Read the latest press releases and news articles about transplantation medicine, innovations in the care of transplant patients and ImmunoFree.
Kyle Clark teared up as he made calls to his family from an intensive care unit at a hospital in China, where he’d been placed on dialysis.
In yet another sign of xenotransplantation creeping toward reality, a medical team at NYU Langone Health announced Tuesday that, for the third time, a kidney from a genetically modified pig had been transplanted into a living patient.
A new lawsuit filed Aug. 20 in federal court in Portland sheds light on the enormous financial and human costs of the complex clinical trials that underlie modern pharmaceutical breakthroughs.
At its 2024 Awards Gala, held June 20, 2024, at The Plaza Hotel in New York City to honor kidney donors and the achievements of the American transplant industry, the National Kidney Registry presented the Terasaki Medical Innovation Award to Dr. Joe Leventhal. The Terasaki Medical Innovation Award is given to an individual or organization…
Immunofree, a company advancing stem cell technology to eliminate the need for immunosuppressive medications in transplant patients, congratulates Dr. Robert Montgomery on winning the prestigious Jacobson Innovation Award from the American College of Surgeons. The award was presented to Dr. Montgomery on June 14, 2024, at the Chicago History Museum at a dinner in his…
Surgeons at NYU Langone Health performed the first combined mechanical heart pump and gene-edited pig kidney transplant surgery.
In the fall of 2021, Gabriel Arias felt like his body was “rotting from the inside.” He was diagnosed with acute myeloid leukemia, a form of blood cancer so aggressive that doctors had him hospitalized the day of his biopsy.
Drs. Ephraim Fuchs and Joseph Leventhal were among the esteemed speakers at the 6th International Sam Strober Workshop on Clinical Immune Tolerance Research, which was held March 25–26, 2024, at Oxford University’s Exeter College. This year’s event, with a focus on autoimmunity, aimed to expand the dialogue surrounding transplantation tolerance and autoimmune regulation. Drs. Fuchs…
The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.